iPSC-Derived Myoblast kit (AA)
Applied StemCell has developed an efficient integration-free method to differentiate high-quality myoblasts from human iPSCs with further differentiation into myotubes and skeletal muscle cells. The differentiated myoblasts recapitulate the phenotype and functional parameters of primary and in vivo myoblasts. We provide cryopreserved, myoblasts differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from fibroblasts of an African-American male donor. These highpurity (≥90%) cells express high level of myoblast biomarkers (CD56, Pax7, Myogenin) (Figure 1) and form mature myotubes (skeleton muscle) characterized by elongated, multi-nucleated structures and the expression of myotube marker alpha-MHC (Figure 2) in 4-6 days. To harness the full potential of our myoblasts, we also provide optimized, serum-free Myoblast Culture Media (ASE-9706MBM) and Myotube Formation Media (ASE-9706MTM) that supports robust maintenance and functionality of the myoblasts/myotubes in culture. These differentiated myoblasts/myotubes can be used as control lines to compare phenotype and functionality of patient-derived and genome edited iPSC-derived myoblasts/myotubes, for coculture models with motor neurons (ASE-9701), as well as for toxicity and drug screening.

Reviews

There are no reviews yet.

Be the first to review “ASE-9706”

Your email address will not be published. Required fields are marked *